Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Notes on human behavioural pharmacotoxicology.

D De Maio1

  • 1Psychiatric Service, Ospedale Fatebenefratelli-Oftalmico, Milan, Italy.

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lithium ratio, phospholipids and the incidence of side effects.

Progress in neuro-psychopharmacology & biological psychiatry·1994
Same author

Lithium-TCA induced malignant syndrome. Case report.

Progress in neuro-psychopharmacology & biological psychiatry·1991
Same author

Clinical notes on buspirone.

Pharmacology, biochemistry, and behavior·1988
Same author

Technological society: its impact on youth.

Topics in clinical nursing·1983
Same author

Evaluation of circadian, circaseptan, and circannual periodicity of attempted suicides.

Chronobiologia·1982
Same author

[Psychiatric experience in and outside the hospital at the Fatebenefratelli Hospital in Milan].

Annales medico-psychologiques·1980

Psychopharmacological therapy can cause collateral behavioral effects, often mistaken for pathological conditions. Human Behavioral Pharmacotoxicology, encompassing memory and social withdrawal, requires greater research and regulatory attention.

Area of Science:

  • Psychopharmacology
  • Neuroscience
  • Behavioral Science

Background:

  • Psychopharmacological therapies have been used for 30 years.
  • Collateral behavioral effects are often overlooked or misdiagnosed.
  • Distinguishing between behavioral modifications and pathological conditions is challenging.

Purpose of the Study:

  • To identify and define "collateral behavioral effects" of psychopharmacological therapy.
  • To highlight the scope of Human Behavioral Pharmacotoxicology.
  • To advocate for increased attention to these effects from researchers and health authorities.

Main Methods:

  • Review of 30 years of psychopharmacological therapy data.
  • Analysis of behavioral changes associated with medication.

Related Experiment Videos

  • Categorization of effects within the framework of Human Behavioral Pharmacotoxicology.

    • Main Results:

    • Identification of "collateral behavioral effects" as a distinct phenomenon.
    • Examples include memory impairment, learning difficulties, reality distortion, paradoxical reactions, "makefobic" behavior, passivity, and social withdrawal.
    • These effects are often confused with pathological conditions.

    Conclusions:

    • Collateral behavioral effects are a significant, yet underrecognized, aspect of psychopharmacology.
    • Human Behavioral Pharmacotoxicology encompasses a range of cognitive and social-behavioral changes.
    • Further research and regulatory oversight are crucial for patient safety and effective treatment.